Chinese Regulator Approves Hutchmed Drug for Liver Cancer Treatment

Health authorities in China have granted approval for a new Hutchmed pharmaceutical treatment targeting liver cancer, expanding available therapeutic options.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

morningstarDanish3d ago

Hutchmed drug approved in China for liver cancer - Morningstar

Hutchmed drug approved in China for liver cancer Morningstar

Read full article →

Chinese Regulator Approves Hutchmed Drug for Liver Cancer Treatment

Sources

Hutchmed drug approved in China for liver cancer - Morningstar

Related Stories

Shein shares plunge in Hong Kong debut after long-awaited IPO

Jollibee Selects Hong Kong for International Unit Listing

Indonesia Inflation Accelerates to Over 3 Percent in August

Japan’s Benchmark Bond Yield Hits 3% for First Time in Three Decades